UroGen Pharma Ltd. (URGN) Profit Margins
Over the twelve months to 2026-06-30, UroGen Pharma Ltd. (URGN) had gross margin 90.8%, operating margin -35.3%, net margin -51.7%, free cash flow margin -84.3%, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
URGNUroGen Pharma Ltd.Follow URGN — free
—
Price chart with a free account
- Market cap
- 1.7B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 5 Nov, in 12 days
| Line | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 92.6% | -59.8% | 100.0% | 91.4% | 89.3% | 88.1% | 88.7% | 90.2% | 88.7% | 90.8% | |
| Operating margin | -244.5% | -6842.2% | -608211.1% | -1074.2% | -192.1% | -122.8% | -79.2% | -107.1% | -113.7% | -35.3% | |
| Net margin | -245.2% | -6707.2% | -584144.4% | -1088.9% | -230.7% | -170.6% | -123.6% | -140.4% | -139.8% | -51.7% | |
| FCF margin | -120.6% | -3359.4% | -396344.4% | -907.7% | -178.3% | -136.4% | -92.6% | -107.4% | -148.2% | -84.3% |
USD millions · SEC XBRL
UroGen Pharma Ltd. — questions
- What is UroGen Pharma Ltd.'s gross margin?
- 90.8% over the twelve months to 2026-06-30.
- What is UroGen Pharma Ltd.'s operating margin?
- -35.3% over the twelve months to 2026-06-30.
- What is UroGen Pharma Ltd.'s net profit margin?
- -51.7% over the twelve months to 2026-06-30.
Every figure on this page comes from UroGen Pharma Ltd.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.